drugset / Trial / NCT00640679

Abrupt Versus Tapered Interruption of Chronic Clopidogrel Therapy After DES Implantation

NCT00640679 ↗

Phase 4 Terminated 782 enrolled German Heart Center Munich
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The hypothesis to be tested is that gradual clopidogrel therapy cessation is associated with a superior clinical outcome compared with abrupt cessation (superiority hypothesis).

Timeline

Start
2008-04
Primary completion
2012-08
Completion
2012-08

Outcome

Outcome not reported

Stopped (Enrollment): “Due to slow enrollment the study was stopped prematurely.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 75 mg —